Drug-resistant Mycobacterium tuberculosis and atypical mycobacteria isolated from patients with suspected pulmonary tuberculosis in Honduras

Chest

Volumn 111, Issue 1, 1997, Pages 148-153

  Pineda Garcia, Lelany ^a,b   Ferrera, Annabelle ^a   Galvez, Carlos Alvarado ^a   Hoffner, Sven E ^b,c,d  

^a NATIONAL AUTONOMOUS UNIVERSITY OF HONDURAS   (Honduras)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

atypical mycobacteria; drug resistance; Honduras; multidrug resistant tuberculosis (MDR TB); tuberculosis

Indexed keywords

AMIKACIN; CIPROFLOXACIN; KANAMYCIN; PYRAZINAMIDE;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; DRUG SENSITIVITY; HONDURAS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUBERCULOSIS;

EID: 0031018377     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.1.148     Document Type: Article

References (21)

1. Sudre P, ten Dam G, Kochi A, Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992; 70:149-59
2. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-26
3. Snider ED, La Montague JR. The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis. J Infect Dis 1994; 169:1189-96
4. Sepkowitz KA, Raffalli J, Riley L, et al. Tuberculosis in the AIDS era. Clin Microbiol Rev 1995; 8: 180-99
5. WHO guidelines for surveillance of Drug Resistance in Tuberculosis. Document WHO/TB/94.178 Geneva: World Health Organization, 1994
6. Dean AG, Dean JA, Burton AH, et al. Epi Info, version 5: a word processing database, and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control, 1990
7. Tuberculosis guide for low income countries. 3rd ed. Paris: International Union Against Tuberculosis and Lung Disease, 1994
8. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III. Atlanta: Centers for Disease Control, Department of Health and Human Services, 1985
9. Rogal T, Wolters J, Fhlor T, et al. Toward a phylogeny and definition of species at the molecular level within the genus Mycobacteria. Int J Syst Bacteriol 1990; 40:323-30
10. van Embden J, Cave D, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31:406-09
11. Siddiqi SH, Libonati JP, Middlebrook G. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 1981; 13:908-12
12. Tarrand JJ, Gröschel DHM. Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol 1985: 21: 941-45
13. Hoffner SE, Svenson SB. Källenius G. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol 1987; 6:530-35
14. Hoffner SE, Källenius G. Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin. Eur J Clin Microbiol Infect Dis. 1988; 7:188-90
15. Costello HD, Caras GJ, Snider D Jr. Drug resistance among previously treated tuberculosis patients, a brief report. Am Rev Respir Dis 1980; 121:313-16
16. Riley WL, Arathoon E, Loverde VD. The epidemiologic patterns of drug resistant Mycobacterium tuberculosis infections: a community-based study. Am Rev Respir Dis 1989; 139:1282-85
17. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328:527-32
18. Passannante MR, Gallegher CT, Reichman LB. Preventive therapy for contacts of multidrug resistant tuberculosis: a Delphi survey. Chest 1994; 106:431-34
19. Stevens JP, Daniel TM. Chemoprophylaxis of multidrug-resistant tuberculosis infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide: a decision analysis. Chest 1995; 108:712-17
20. Githui W, Nunn P, Juma E, et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tuberc Lung Dis 1992; 73:203-09
21. Laszlo A, de Kantor IN. A random sample survey of initial drug resistance among tuberculosis cases in Latin America. Bull World Health Organ 1994; 72:603-10